aTYR PHARMA INC - COMMON STOCK (ATYR)

CUSIP: 002120202

Q2 2020 13F Holders as of 30 Jun 2020

Holder snapshot 6 signals
Share change
+346,503
SEC-reported price per share
$4.44
Indexed holders
21
Value change
+$1,598,388
Number of buys
10
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
98,130,711

Security key

002120202

Report period

Q2 2020

Indexed institutions

21

Top holders

10

Ownership snapshot

Top reported holders of ATYR - aTYR PHARMA INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FEDERATED HERMES, INC.
Disclosed value leader
FEDERATED HERMES, INC.
Comparable rows
0/15
Latest evidence
31 Mar 2020
13F Highest disclosed value: $4,522,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FEDERATED HERMES, INC. has the largest disclosed position value at $4.52M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FEDERATED HERMES, INC.'s linked filing trail.
Disclosed position value Top 5
FEDERATED HERMES, INC. $4.52M
FMR LLC $3.93M
Alyeska Investment Group, L.P. $2.07M
VIKING GLOBAL INVESTORS LP $1.64M
VANGUARD GROUP INC $621K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FEDERATED HERMES, INC.
13F
Company
13F
—
denominator unverified
$4,522,000
1,615,000 shares
— 31 Mar 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$3,928,000
1,402,874 shares
— 31 Mar 2020
Alyeska Investment Group, L.P.
13F
Company
13F
—
denominator unverified
$2,067,000
738,288 shares
— 31 Mar 2020
VIKING GLOBAL INVESTORS LP
13F
Company
13F
—
denominator unverified
$1,645,000
587,444 shares
— 31 Mar 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$621,000
221,938 shares
— 31 Mar 2020
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$585,000
209,000 shares
— 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
21
Shares
5,472,169
Indexed holders
21
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 indexed holders
21
Q2 2020 indexed holders
21
Indexed holder difference
0
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .